NCT07608237

Brief Summary

The purpose of this pilot study is to determine feasibility of a randomized controlled trial comparing labral repair versus reconstruction in patients over 40 years of age undergoing hip arthroscopy for FAIS. Specifically, we aim to: (1) estimate the proportion of eligible patients providing consent, (2) estimate the magnitude of the between-groups difference in the primary outcome (International Hip Outcome Tool \[iHOT\] - 33) to aid in sample size calculation for the full study, (3) estimate the compliance in completing the proposed outcome measures to determine the burden of questionnaire completion.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for not_applicable

Timeline
28mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 27, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2028

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

May 27, 2026

Status Verified

May 1, 2026

Enrollment Period

2.1 years

First QC Date

May 19, 2026

Last Update Submit

May 19, 2026

Conditions

Keywords

labral repairlabral reconstruction

Outcome Measures

Primary Outcomes (1)

  • International Hip Outcome Tool (iHOT) - 12

    Baseline to 2 years post surgical follow-up

Secondary Outcomes (8)

  • Hip Outcome Score- Activities of Daily Living (HOS-ADL)

    Baseline to 2 years post surgical follow-up

  • Hip Outcome Score- Sport Specific Subscale (HOS-SSS)

    Baseline to 2 years post surgical follow-up

  • modified Harris Hip Score (mHHS)

    Baseline to 2 years post surgical follow-up

  • EQ-5D

    Baseline to 2 years post surgical follow-up

  • Cost Diary

    6 weeks to 2 years post surgical follow-up

  • +3 more secondary outcomes

Study Arms (2)

Labral Repair

ACTIVE COMPARATOR

Standard arthroscopic osteochondroplasty and concomitant labral repair, using a minimum of two suture anchors.

Procedure: Labral Repair

Labral Reconstruction

ACTIVE COMPARATOR

Standard arthroscopic osteochondroplasty and subsequent labral reconstruction with allograft.

Procedure: Labral Reconstruction

Interventions

Labral RepairPROCEDURE

Standard arthroscopic osteochondroplasty and concomitant labral repair, using a minimum of two suture anchors.

Labral Repair

Standard arthroscopic osteochondroplasty and subsequent labral reconstruction with allograft.

Labral Reconstruction

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cam or pincer morphology who have failed a trial of conservative treatment

You may not qualify if:

  • Moderate concomitant OA (Tönnis 2+)
  • Have had previous hip surgery
  • Active joint or systemic infection
  • Significant muscle paralysis
  • Inflammatory arthropathies
  • Significant medical comorbidity that may alter effectiveness of surgical intervention
  • Active smoker
  • Major medical illness
  • Unable to speak and understand English
  • Psychiatric illness that precludes informed consent
  • Unwilling to be followed for 2 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fowler Kennedy Sport Medicine Clinic

London, Ontario, N6A 3K7, Canada

Location

MeSH Terms

Conditions

Femoracetabular Impingement

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2026

First Posted

May 27, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

May 27, 2026

Record last verified: 2026-05

Locations